🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Prospective, open-labeled, multicenter cohort trial for validation of the r...
Status
Unknown
Location
Multiple Locations
Start Date
2016-07
Trial ID
NCT02815410
Treatments Being Tested
Epilepsy, a condition where individuals are prone to recurrent epileptic se...
Status
Unknown
Location
Birmingham Children's Hospital
Start Date
2015-01
Trial ID
NCT02205931
Treatments Being Tested
RATIONALE: Giving low doses of chemotherapy, such as fludarabine and cyclop...
Status
Terminated
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2008-06-23
Trial ID
NCT00489281
This long-term open label follow-up trial gave pediatric subjects suffering...
Status
Completed
Location
Multiple Locations
Start Date
2000-05
Trial ID
NCT00545012
Treatments Being Tested
This clinical trial will test whether AGB101 (low-dose levetiracetam, 220 m...
Status
Recruiting
Location
Johns Hopkins
Start Date
2023-09-28
Trial ID
NCT05824728
Treatments Being Tested
RATIONALE: Celecoxib may stop the growth of tumor cells by blocking the enz...
Status
Terminated
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2003-10
Trial ID
NCT00068770
Treatments Being Tested
To define the effective dose and tolerability of levetiracetam in individua...
Status
Completed
Location
Sleep Health Centers
Start Date
2003-11
Trial ID
NCT00247364
Treatments Being Tested
The aim of the study is to compare between the role of dapagliflozin versus...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-08-20
Trial ID
NCT06750458
Treatments Being Tested
THe objective of this study is to compare the rate and extent of absorption...
Status
Completed
Location
CEDRA Clinical Research, LLC
Start Date
2007-01
Trial ID
NCT00859521
Treatments Being Tested
This study will provide information on the pharmacokinetics, safety and eff...
Status
Completed
Location
MUMC
Start Date
2014-08
Trial ID
NCT02421068